Teclistamab is a bi-specific antibody targeting CD3 and B-cell maturation antigen (BCMA), used in relapsed or refractory multiple myeloma (MM) beyond first-line therapy. Even though it achieves ...
Invariant natural killer T (iNKT) cells are a unique subset of T lymphocytes with allogeneic potential and strong solid tumour-homing capacity, making them attractive for cancer immunotherapy. Unlike ...
Cytek Biosciences, Inc. has launched the Cytek® Muse® Micro, an enhanced version of its original Guava® Muse® cell analyzer, aimed at making advanced cell analysis more accessible and affordable. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results